Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Gastrin radioimmunoassay

Journal Article · · Clin. Chem. (Winston-Salem, N.C.); (United States)
OSTI ID:5639265
The radioimmunoassay for gastrin is based on competition by unlabeled antigen, i.e., gastrin in the form of synthetic human gastrin I heptadecapeptide (SHG) as standard and (or) gastrin unknown with radiolabeled gastrin (/sub 125/I-SHG), for specific binding sites on antibodies to gastrin, produced in experimental animals. The concentrations of antibody and radiolabeled antigen are kept constant, and standard calibration curves are established by including various concentrations of unlabeled gastrin in the incubation tubes. The antigen, gastrin, is added to concentrations in excess of antibody, to ensure competition between /sub 125/I-SHG and gastrin for the available antibody-binding sites. In this system of competitive inhibition, the proportion of antibody-bound /sub 125/I-SHG is inversely related to the quantity of unlabeled gastrin included in the incubation mixture. Unlabeled antigen (gastrin) available for binding by antibody is either the gastrin present in the standards included in the construction of calibration curves or gastrin present in the unknown samples to be measured. As with other radioimmunoassay techniques, radioimmunoassay of gastrin requires: (a) production of antibodies specific for gastrin, (b) availability of a pure form of the peptide for radiolabeling, (c) preparation of a radiolabeled form of gastrin, and (d) an effective method of separating antibody-bound peptide from free.
Research Organization:
Univ. of Florida Coll. of Medicine, Gainesville
OSTI ID:
5639265
Journal Information:
Clin. Chem. (Winston-Salem, N.C.); (United States), Journal Name: Clin. Chem. (Winston-Salem, N.C.); (United States) Vol. 28:2; ISSN CLCHA
Country of Publication:
United States
Language:
English